Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GGHCX vs SCHLX overlap: 51% of top holdings shared

Bottom line

How much do GGHCX and SCHLX overlap?

51% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 41.4% of GGHCX's assets and 45.6% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

GGHCXSCHLX
Weight overlap (top 25)51%
Shared holdings9
Weight in shared holdings41.4%45.6%
Total positions8265
Expense ratio1.07%1.06%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings GGHCX and SCHLX have in common

Holding% of GGHCX% of SCHLXOverlap
Eli Lilly and Co.10.59%13.85%10.59%
Johnson & Johnson6.76%6.19%6.19%
UnitedHealth Group Inc.6.17%5.73%5.73%
Merck & Co., Inc.4.59%4.85%4.59%
AbbVie Inc.4.03%4.90%4.03%
Gilead Sciences, Inc.3.63%2.78%2.78%
Cardinal Health, Inc.2.10%1.34%1.34%
Vertex Pharmaceuticals Inc.2.01%2.45%2.01%
Thermo Fisher Scientific Inc.1.55%3.46%1.55%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. argenx SE — 3.24%
  3. CVS Health Corp. — 2.52%
  4. Welltower Inc. — 2.34%
  5. BrightSpring Health Services, Inc. — 2.20%
  6. Royalty Pharma PLC — 2.13%
  7. Guardant Health, Inc. — 2.04%
  8. Invesco Private Government Fund — 1.80%
  9. Axsome Therapeutics, Inc. — 1.58%
  10. Edwards Lifesciences Corp. — 1.56%
  11. Invesco Treasury Portfolio — 1.56%
  12. BridgeBio Pharma, Inc. — 1.43%
  13. Waters Corp. — 1.41%
  14. IQVIA Holdings Inc. — 1.32%
  15. U C B S.a. — 1.24%

Only in SCHLX

  1. AstraZeneca PLC — 3.80%
  2. Novartis AG — 2.90%
  3. Amgen Inc — 2.88%
  4. Intuitive Surgical Inc — 2.69%
  5. Stryker Corp — 2.61%
  6. Abbott Laboratories — 2.39%
  7. Danaher Corp — 2.13%
  8. Boston Scientific Corp — 2.10%
  9. McKesson Corp — 2.05%
  10. Novo Nordisk A/S — 1.73%
  11. Medtronic PLC — 1.54%
  12. Bristol-Myers Squibb Co — 1.50%
  13. Regeneron Pharmaceuticals Inc — 1.43%
  14. Cencora Inc — 1.26%
  15. Roche Holding AG — 1.24%

Asset mix

Asset typeGGHCXSCHLX
Stocks97.5%99.6%
Cash & short-term funds8.8%0.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryGGHCXSCHLX
US93.5%85.7%
CH2.7%5.2%
GB3.1%3.8%
NL3.4%1.0%
DK1.1%1.7%
IE0.6%1.5%
BE1.2%—
FR—1.0%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do GGHCX and SCHLX overlap?
About 51% by weight. 9 securities appear in both funds' top 25 holdings; they make up 41.4% of GGHCX's assets and 45.6% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do GGHCX and SCHLX have in common?
The largest shared holdings are Eli Lilly and Co., Johnson & Johnson, UnitedHealth Group Inc., Merck & Co., Inc., AbbVie Inc..
Should I own both GGHCX and SCHLX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, GGHCX or SCHLX?
GGHCX is broader, with 82 positions versus 65 for SCHLX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.